## IgG Subclass Deficiency — The Most Likely Diagnosis **Key Point:** In this clinical vignette, the patient has **IgG 450 mg/dL** (significantly below the normal floor of 700 mg/dL), **IgA <5 mg/dL**, and **IgM 35 mg/dL** (borderline low). While IgA is strikingly low, the question asks which deficiency is **most likely responsible** for the recurrent sinopulmonary infections and bronchiectasis. The significantly reduced IgG — the dominant serum immunoglobulin for systemic and respiratory defense — is the primary driver of this clinical picture. ### Why IgG Subclass Deficiency (Option B) Is Correct **High-Yield:** IgG is the most important immunoglobulin for defense against encapsulated bacteria (e.g., *Streptococcus pneumoniae*, *Haemophilus influenzae*) that cause sinopulmonary infections. IgG subclass deficiency — particularly IgG2 (which handles polysaccharide antigens) and IgG3 — is a well-recognized cause of: - Recurrent sinopulmonary infections - Bronchiectasis from repeated lower respiratory tract infections - Normal or near-normal total IgG, but with selective subclass reduction In this patient, total IgG is **450 mg/dL**, which is **substantially below normal** (normal: 700–1600 mg/dL), indicating a clinically significant IgG deficiency. This level of IgG reduction is sufficient to impair opsonization and complement-mediated killing of encapsulated organisms, directly explaining the bronchiectasis. | Feature | IgG Deficiency | Selective IgA Deficiency | |---|---|---| | **IgG level** | Low (as in this case: 450 mg/dL) | Normal | | **IgA level** | Normal or low | <5 mg/dL (isolated) | | **IgM level** | Normal or low | Normal | | **Clinical impact** | Severe recurrent sinopulmonary infections, bronchiectasis | Often asymptomatic; mucosal infections if symptomatic | | **Primary defense role** | Systemic opsonization, complement activation | Mucosal immune exclusion | ### Why Selective IgA Deficiency (Option A) Is Less Likely to Be the Primary Cause **Clinical Pearl:** True **selective** IgA deficiency is defined as IgA <5 mg/dL with **normal IgG and IgM**. In this patient, IgG is significantly reduced (450 mg/dL) and IgM is borderline low — this pattern is **not** consistent with selective IgA deficiency. The combination of low IgG + low IgA + borderline low IgM is more consistent with **Common Variable Immunodeficiency (CVID)** or a combined deficiency where IgG subclass deficiency is the dominant pathological mechanism. Furthermore, many patients with isolated IgA deficiency are **asymptomatic**, and the severity of bronchiectasis in this case is better explained by the IgG deficit. ### Differential Considerations - **IgM deficiency (Option C):** Isolated IgM deficiency is rare; IgM here is only borderline low and not the primary driver. - **IgE deficiency (Option D):** IgE is involved in allergic and anti-parasitic responses; its deficiency does not cause recurrent bacterial sinopulmonary infections. ### Management Implications **Key Point:** Patients with significant IgG deficiency benefit from **IVIG replacement therapy** (target trough IgG >500–700 mg/dL), which reduces infection frequency and slows bronchiectasis progression. Caution: if anti-IgA antibodies are present (as may occur in patients with concurrent low IgA), use **IgA-depleted IVIG** to prevent anaphylaxis. [cite: Harrison's Principles of Internal Medicine, 21e, Ch. 372; Stiehm's Immune Deficiencies, 2014]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.